×
About 1,490 results

ALLMedicine™ Pituitary Tumors Center

Research & Reviews  533 results

A Rare Case of Pituitary Carcinoma With Bone Metastases: 68Ga-DOTATATE PET/CT Findings.
https://doi.org/10.1097/RLU.0000000000004029
Clinical Nuclear Medicine; Filizoglu N, Ozguven S

Jan 14th, 2022 - Pituitary carcinomas are extremely rare and aggressive tumors that comprise only 0.2% of all pituitary tumors. Because of its rarity, pituitary carcinomas are difficult to diagnose. Conventional imaging methods are inadequate to detect metastatic ...

Insulin-like growth factor-1 as predictive factor of difficult laryngoscopy in patients...
https://doi.org/10.1016/j.jocn.2021.09.021
Journal of Clinical Neuroscience : Official Journal of Th... Iacovazzo C, de Bonis C et. al.

Dec 6th, 2021 - Growth hormone (GH)-producing pituitary tumors account for 10 to 15% of pituitary tumors. The hypersecretion of GH may induce changes in the airway anatomy through the activation of Insulin-like Growth factor 1(IGF-1) pathway. We sought investigat...

Shrinkage of a pituitary metastasis of melanoma induced by pembrolizumab: a case report.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582141
Journal of Medical Case Reports; Giuffrida G, Ferraù F et. al.

Nov 12th, 2021 - Pituitary metastases are rare, often deriving from lung or breast cancer owing to the upper vena cava proximity. Pituitary metastases can manifest with signs and symptoms of pituitary tumors, consequent to mass effect (headache, visual impairment)...

see more →

Guidelines  3 results

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Pre...
https://doi.org/10.1227/NEU.0000000000001388
Neurosurgery Newman SA, Turbin RE et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are the most frequent pituitary tumors. Visual symptoms from NFPAs are common and include visual field defects, loss of central vision, and motility problems resulting in diplopia. To create evidence-based...

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on th...
https://doi.org/10.1227/NEU.0000000000001386
Neurosurgery Aghi MK, Chen CC et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are the most frequent pituitary tumors. To create evidence-based guidelines for the initial management of NFPAs. A multidisciplinary task force composed of physician volunteers and evidence-based medicine-...

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Pos...
https://doi.org/10.1227/NEU.0000000000001392
Neurosurgery Ziu M, Dunn IF et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are the most frequent pituitary tumors. Due to the lack of hormonal hypersecretion, posttreatment follow-up evaluation of NFPAs is challenging. To create evidence-based guidelines in an attempt to formulat...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  14 results

Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
https://clinicaltrials.gov/ct2/show/NCT02351700

Oct 21st, 2021 - Post-operative pain control is a common concern patients have when they consider undergoing a surgical procedure. Although effective for treating acute pain, opioid analgesics are also associated with dose-dependent adverse effects, including cons...

Nasal Packing Following Endoscopic Endonasal Pituitary Resection
https://clinicaltrials.gov/ct2/show/NCT03677713

Sep 9th, 2021 - BACKGROUND AND CLINICAL SIGNIFICANCE Over the past decade, the surgical method for removing pituitary tumors has shifted from a microscopic resection technique performed exclusively by a neurosurgeon, to an endoscopic resection done as a team with...

Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
https://clinicaltrials.gov/ct2/show/NCT03038308

Jul 30th, 2021 - Treatment of prolactin secreting pituitary tumors with traditional ergot dopamine agonist drugs can be limited by medication side effects, pharmacologic resistance, and by concerns regarding the potential risk of cardiac valve disease. The overall...

Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
https://clinicaltrials.gov/ct2/show/NCT01556230

Jul 13th, 2021 - PROTOCOL I: Prospective Study of the outcome of conservative non-surgical management of patients with asymptomatic, clinically non-functioning (CNF) pituitary lesions. This protocol will evaluate prospectively the outcome of non-surgical managemen...

Infraorbital Nerve Block for Endoscopic Transsphenoidal Approach to Remove Pituitary Tumor
https://clinicaltrials.gov/ct2/show/NCT04785222

Mar 5th, 2021 - Infraorbital nerve- The infraorbital nerve exits from the infraorbital foramen. It is a branch of the maxillary nerve, the second division of the trigeminal nerve, the fifth cranial nerve. The infraorbital nerve is a pure sensory nerve innervates ...

see more →

News  23 results

Memorial Sloan-Kettering Cancer Center: A Venerable Institution That Shows No Signs of Slowing Down
https://www.onclive.com/view/obtn_may_2010_mskcc

Dec 5th, 2020 - Founded in 1884, the New York City institute known today as Memorial Sloan-Kettering Cancer Center (MSKCC) is the world’s oldest and largest private cancer center. The facility started out as the New York Cancer Hospital. A new edifice was built i...

Dr. Krishnamurthi on CAPTEM as Treatment for Neuroendocrine Tumors
https://www.onclive.com/view/dr-krishnamurthi-on-captem-as-treatment-for-neuroendocrine-tumors

Dec 4th, 2020 - Smitha Krishnamurthi, MD, a medical oncologist and associate professor of medicine at University Hospitals Case Medical Center and Case Western Reserve University, discusses a prospective phase II study of capecitabine and temozolomide (CAPTEM) fo...

Don't Use Growth Hormone for Anti-Aging, Say New Guidelines
https://www.staging.medscape.com/viewarticle/922195

Dec 5th, 2019 - The 2019 Guidelines for Management of Growth Hormone Deficiency in Adults and Patients Transitioning from Pediatric to Adult Care issued by two key US endocrine societies cover important developments in the decade since the previous version.   The...

New Clinical Practice Guidelines, November 2017
https://reference.medscape.com/viewarticle/888107_10

Nov 8th, 2017 - Pituitary Tumors and Carcinomas European Society of Endocrinology Recommend all pituitary tumors undergo histopathologic analysis, which should include, at a minimum, immunodetection of pituitary hormones and Ki-67 proliferative index evaluation. ...

What Do You Consider to Be the Top Medical Advances of the Past 20 Years?
https://reference.medscape.com/viewarticle/845121_8

May 27th, 2015 - Which of the following would you say has been the biggest advance in endocrinology over the past 20 years? Your Peers Chose: The discovery of leptin 0% Introduction of tyrosine kinase inhibitors (TKIs) in the management of advanced thyroid cancers...

see more →

Patient Education  12 results see all →